Shan H - Search Results

1

Discovery of 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo.

Yang J, Liu Y, Lan S, Yu S, Ma X, Luo D, Shan H, Zhong X, Yan G, Li R. Yang J, et al. Among authors: shan h. J Med Chem. 2022 Oct 13;65(19):12781-12801. doi: 10.1021/acs.jmedchem.2c00572. Epub 2022 Oct 3. J Med Chem. 2022. PMID: 36191148

2

Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors.

Yan G, Pu C, Lan S, Zhong X, Zhou M, Hou X, Yang J, Shan H, Zhao L, Li R. Yan G, et al. Among authors: shan h. Eur J Med Chem. 2019 Sep 15;178:667-686. doi: 10.1016/j.ejmech.2019.06.021. Epub 2019 Jun 13. Eur J Med Chem. 2019. PMID: 31228810

3

Discovery of 4-(3,5-dimethoxy-4-(((4-methoxyphenethyl)amino)methyl)phenoxy)-N-phenylaniline as a novel c-myc inhibitor against colorectal cancer in vitro and in vivo.

Yang J, Cao C, Luo D, Lan S, Luo M, Shan H, Ma X, Liu Y, Yu S, Zhong X, Li R. Yang J, et al. Among authors: shan h. Eur J Med Chem. 2020 Jul 15;198:112336. doi: 10.1016/j.ejmech.2020.112336. Epub 2020 Apr 26. Eur J Med Chem. 2020. PMID: 32387836

4

Discovery of a PROTAC targeting ALK with in vivo activity.

Yan G, Zhong X, Yue L, Pu C, Shan H, Lan S, Zhou M, Hou X, Yang J, Li R. Yan G, et al. Among authors: shan h. Eur J Med Chem. 2021 Feb 15;212:113150. doi: 10.1016/j.ejmech.2020.113150. Epub 2021 Jan 2. Eur J Med Chem. 2021. PMID: 33453602

5

Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design.

Yan G, Zhong X, Pu C, Yue L, Shan H, Lan S, Zhou M, Hou X, Yang J, Li D, Fan S, Li R. Yan G, et al. Among authors: shan h. J Med Chem. 2021 Feb 11;64(3):1558-1569. doi: 10.1021/acs.jmedchem.0c01707. Epub 2021 Jan 20. J Med Chem. 2021. PMID: 33471528

6

Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold.

Shan H, Ma X, Yan G, Luo M, Zhong X, Lan S, Yang J, Liu Y, Pu C, Tong Y, Li R. Shan H, et al. Eur J Med Chem. 2021 Jul 5;219:113432. doi: 10.1016/j.ejmech.2021.113432. Epub 2021 Apr 3. Eur J Med Chem. 2021. PMID: 33857728

7

Lead optimization to improve the antiviral potency of 2-aminobenzamide derivatives targeting HIV-1 Vif-A3G axis.

Zhong X, Luo R, Yan G, Ran K, Shan H, Yang J, Liu Y, Yu S, Pu C, Zheng Y, Li R. Zhong X, et al. Among authors: shan h. Eur J Med Chem. 2021 Nov 15;224:113680. doi: 10.1016/j.ejmech.2021.113680. Epub 2021 Jul 1. Eur J Med Chem. 2021. PMID: 34245947

8

Case Report: Severe Diarrhea Caused by Cryptosporidium Diagnosed by Metagenome Next-Generation Sequencing in Blood.

Shan H, Wei C, Zhang J, He M, Zhang Z. Shan H, et al. Infect Drug Resist. 2023 Sep 1;16:5777-5782. doi: 10.2147/IDR.S422799. eCollection 2023. Infect Drug Resist. 2023. PMID: 37675126 Free PMC article.

9

A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system.

Zhang J, Guo Y, Wei C, Yan Y, Shan H, Wu B, Wu F. Zhang J, et al. Among authors: shan h. Front Pharmacol. 2024 Jun 21;15:1363501. doi: 10.3389/fphar.2024.1363501. eCollection 2024. Front Pharmacol. 2024. PMID: 38974040 Free PMC article.

10

Severe cutaneous adverse reactions due to antibiotics therapy: a pharmacovigilance analysis of FDA adverse event reporting system events.

Zhou L, Yang J, Xiao M, Shan H, Liu M, Lu Y, Zou Y, Wu B. Zhou L, et al. Among authors: shan h. Expert Opin Drug Saf. 2023 Nov 8:1-8. doi: 10.1080/14740338.2023.2278685. Online ahead of print. Expert Opin Drug Saf. 2023. PMID: 37937960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,710 results

Search Page

Filters